SecSonar.com

DaVita Inc. (DVA)

DaVita Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

DaVita Inc. (DVA) is a Medical - Care Facilities company based in US with a market capitalization of $12.6B. Revenue grew 6.5% year-over-year and the company generated $1.3B in free cash flow. This page tracks DVA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 76K employees · IPO Oct 31, 1995

Valuation

Valuation & price

$199.74 · as of May 17, 2026 · -15.0% vs 52w high

23.6

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$235$169$104Jul 25Dec 25Jul 26Jul 7, 25$142.81Jul 9, 25$141.84Jul 11, 25$142.55Jul 15, 25$140.53Jul 17, 25$143.38Jul 21, 25$139.43Jul 23, 25$151.32Jul 25, 25$145.17Jul 29, 25$145.98Jul 31, 25$140.37Aug 4, 25$139.52Aug 6, 25$127.81Aug 11, 25$129.05Aug 13, 25$134.69Aug 15, 25$135.38Aug 19, 25$136.68Aug 21, 25$137.58Aug 25, 25$137.33Aug 27, 25$137.56Aug 29, 25$137.76Sep 3, 25$135.97Sep 5, 25$137.87Sep 9, 25$136.71Sep 11, 25$133.24Sep 16, 25$130.11Sep 18, 25$130.23Sep 22, 25$131.15Sep 24, 25$133.62Sep 26, 25$130.80Sep 30, 25$132.87Oct 2, 25$132.10Oct 6, 25$128.14Oct 8, 25$127.89Oct 10, 25$123.99Oct 14, 25$126.62Oct 16, 25$125.25Oct 21, 25$128.41Oct 23, 25$128.02Oct 27, 25$129.55Oct 29, 25$126.56Oct 31, 25$119.02Nov 4, 25$119.97Nov 6, 25$121.53Nov 10, 25$120.17Nov 12, 25$123.60Nov 14, 25$121.55Nov 18, 25$116.56Nov 20, 25$115.35Nov 25, 25$121.37Nov 28, 25$119.68Dec 2, 25$119.18Dec 4, 25$117.28Dec 8, 25$117.05Dec 10, 25$118.68Dec 12, 25$121.35Dec 16, 25$117.94Dec 18, 25$116.15Dec 22, 25$116.51Dec 24, 25$114.41Dec 29, 25$113.50Jan 2, 26$114.51Jan 6, 26$114.72Jan 8, 26$112.59Jan 12, 26$110.10Jan 14, 26$103.87Jan 16, 26$104.74Jan 21, 26$106.30Jan 23, 26$108.12Jan 27, 26$105.61Jan 29, 26$107.24Feb 2, 26$111.19Feb 4, 26$142.06Feb 9, 26$137.64Feb 11, 26$144.27Feb 13, 26$148.95Feb 18, 26$147.75Feb 20, 26$150.73Feb 24, 26$150.91Feb 26, 26$152.54Mar 2, 26$153.98Mar 4, 26$154.79Mar 6, 26$150.76Mar 10, 26$151.55Mar 12, 26$153.06Mar 17, 26$149.98Mar 19, 26$149.76Mar 23, 26$152.21Mar 25, 26$155.11Mar 27, 26$154.43Mar 31, 26$153.69Apr 2, 26$145.58Apr 7, 26$149.70Apr 9, 26$150.68Apr 13, 26$151.56Apr 15, 26$144.57Apr 17, 26$147.91Apr 22, 26$152.42Apr 24, 26$151.85Apr 28, 26$150.07Apr 30, 26$155.14May 4, 26$154.08May 6, 26$193.88May 8, 26$198.65May 12, 26$200.54May 14, 26$192.58May 18, 26$199.52May 20, 26$196.87May 22, 26$198.52May 28, 26$197.10Jun 1, 26$189.81Jun 3, 26$195.03Jun 5, 26$192.16Jun 9, 26$198.19Jun 11, 26$203.83Jun 15, 26$209.75Jun 17, 26$210.58Jun 22, 26$209.68Jun 24, 26$213.04Jun 26, 26$217.04Jul 2, 26$234.91
$103.8752-week range$234.91
Loading valuation history…

Fundamentals

Key fundamentals

$12.6B

Market cap

6.5%

Revenue growth (YoY)

27.0%

Gross margin

$1.3B

Free cash flow (USD)

$14.3B

Net debt

1.3%

Share dilution

2/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$14.7BFY 2017$10.9BFY 2018$11.4BFY 2019$11.4BFY 2020$11.6BFY 2021$11.6BFY 2022$11.6BFY 2023$12.1BFY 2024$12.8BFY 2025$13.6B
$14.7B$13.6B

Free cash flow by year

2016 → 2025

FY 2016$1.1BFY 2017$1.0BFY 2018$784.5MFY 2019$1.3BFY 2020$1.3BFY 2021$1.3BFY 2022$961.1MFY 2023$1.5BFY 2024$1.5BFY 2025$1.3B
$1.1B$1.3B

Gross margin by year

2021 → 2025

FY 202131.4%FY 202229.3%FY 202331.5%FY 202432.9%FY 202527.0%
31.4%27.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $14.5MRodriguez Javier · Director, Chief Executive Officer · $14.5MJun 17, 2026Filing
  • Insider sellInsider Sell $3.2M · 10b5-1 PlanWaters Kathleen Alyce · Chief Legal & Pub. Affairs Off · $3.2MJun 17, 2026Filing
  • 8-K eventDebt RefinancingJun 8, 2026Filing
  • Insider sellInsider Sell $2.9MHEARTY JAMES O · Chief Compliance Officer · $2.9MMay 18, 2026Filing
  • Insider sellInsider Sell $4.1MMaughan David Paul · Chief Operating Officer, DKC · $4.1MMay 13, 2026Filing
  • Insider sellInsider Sell $9.9MACKERMAN JOEL · CFO and Treasurer · $9.9MMay 11, 2026Filing
  • Insider sellInsider Sell $382K · 10b5-1 PlanHEARTY JAMES O · Chief Compliance Officer · $381.9KMay 8, 2026Filing
  • Insider sellInsider Sell $182.9MBERKSHIRE HATHAWAY INC · 10% Owner · $182.9MMay 5, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing

Questions

Frequently asked questions

What is DaVita Inc.'s market cap?

DaVita Inc. (DVA) has a market capitalization of $12.6B.

What is DVA's P/E ratio?

DVA trades at a price-to-earnings ratio of 23.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

Are insiders buying DVA stock?

SEC Form 4 filings show no open-market insider buys at DaVita Inc. in the last 90 days (7 sells).

Same arena

Related companies in Medical - Care Facilities

SOLV

Solventum Corporation

$13.2B

FMS

Fresenius Medical Care AG & Co. KGaA

$11.6B

EHC

Encompass Health Corporation

$10.6B

THC

Tenet Healthcare Corporation

$15.3B

ENSG

The Ensign Group, Inc.

$9.8B

UHS

Universal Health Services, Inc.

$9.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.